The creation of a monolithic biotech company with the merger of Monsanto and Bayer could allow the industry to reinvent its negative image, but some say it is another step towards leaving bio-tech and genetics intellectual property in too few private hands, and could lead to higher input costs for farmers, say Canadian industry reps. The massive takeover is also just one of more mega-mergers on the horizon. On the Canadian side, âthe biggest concern would be around
Hey, would you like to read this awesome, free story?
Give us your email address.